TCM Biotech International Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	245.07	232.98	504.13	89.85	58.26
Short-Term Investments	300	300	-	0.09	-
Cash & Short-Term Investments	545.07	532.98	504.13	89.94	58.26
Cash Growth	2.27%	5.72%	460.55%	54.38%	70.01%
Accounts Receivable	151.37	139.96	259.08	225.83	190.68
Other Receivables	0.13	1.69	3.61	3.94	0.03
Receivables	151.5	141.65	262.69	229.77	190.71
Inventory	139.09	132.24	208.36	193.25	203.33
Prepaid Expenses	22.71	4.96	4.46	0.65	17.08
Other Current Assets	0.1	0.15	1.51	0.13	0.74
Total Current Assets	858.46	811.98	981.15	513.74	470.11
Property, Plant & Equipment	280.67	291.91	293.71	301.74	285.36
Long-Term Investments	31.68	30	-	-	-
Other Intangible Assets	17.58	5.06	8.01	10.24	13.21
Long-Term Deferred Tax Assets	1.32	1.02	0.98	1.63	4.2
Long-Term Deferred Charges	-	15.66	15.66	15.66	16.26
Other Long-Term Assets	14.47	26.73	23.41	19.87	30.92
Total Assets	1,204	1,182	1,323	862.87	820.06
Accounts Payable	48.38	20.69	64.53	88.81	55.54
Accrued Expenses	-	26.47	50.18	52.01	36.84
Short-Term Debt	-	-	44	44	44
Current Portion of Long-Term Debt	-	3.05	5.19	10.44	9.21
Current Portion of Leases	3.9	3.72	1.68	2.95	1.84
Current Income Taxes Payable	3.39	4.03	2.59	2.35	-
Current Unearned Revenue	10.29	2.84	2.25	2.76	5.12
Other Current Liabilities	48.93	21.11	27.96	21.54	23.38
Total Current Liabilities	114.89	81.9	198.38	224.84	175.93
Long-Term Debt	24.76	28.54	59.69	93.58	104.51
Long-Term Leases	5.09	8.16	4.81	6.49	1.45
Long-Term Unearned Revenue	3.23	3.23	3.23	-	18.2
Pension & Post-Retirement Benefits	-	1.46	1.5	1	1.6
Long-Term Deferred Tax Liabilities	-	0	-	0.01	-
Other Long-Term Liabilities	0.89	-	0.27	0.27	0.16
Total Liabilities	148.86	123.28	267.88	326.2	301.84
Common Stock	590.49	590.49	590.49	475.92	475.92
Additional Paid-In Capital	415.77	415.77	415.77	13.82	13.82
Retained Earnings	49.06	52.87	48.85	47.04	28.47
Comprehensive Income & Other	-	-0.05	-0.07	-0.11	0.01
Shareholders' Equity	1,055	1,059	1,055	536.67	518.22
Total Liabilities & Equity	1,204	1,182	1,323	862.87	820.06
Total Debt	33.75	43.46	115.38	157.46	161
Net Cash (Debt)	511.32	489.52	388.76	-67.52	-102.75
Net Cash Growth	4.45%	25.92%	-	-	-
Net Cash Per Share	8.54	8.29	7.33	-1.38	-2.11
Filing Date Shares Outstanding	62.48	59.05	59.05	49.05	49.05
Total Common Shares Outstanding	62.48	59.05	59.05	49.05	49.05
Working Capital	743.57	730.08	782.78	288.9	294.18
Book Value Per Share	16.89	17.94	17.87	10.94	10.57
Tangible Book Value	1,038	1,054	1,047	526.43	505.01
Tangible Book Value Per Share	16.61	17.85	17.73	10.73	10.30
Land	-	83.08	83.08	83.08	83.08
Buildings	-	197.04	196.97	196.6	194.3
Machinery	-	105.32	101.48	93.09	77.69
Leasehold Improvements	-	14.39	10.33	9.76	3.41

Source: S&P Global Market Intelligence. Standard template. Financial Sources.